DIPG: Shining a light on the deadliest childhood cancer

26/09/2019


Thursday 26 September is the inaugural Childhood Brain Cancer Awareness Day. This year, we shine a light on Diffuse Intrinsic Pontine Glioma (DIPG), the most devastating of all childhood cancers.

'

New gene found in neuroblastoma offers possibility of targeted treatment

31/07/2019


Our researchers have discovered that a gene called JMJD6 plays an important role in the most aggressive form of neuroblastoma. What’s more, they’ve developed a targeted treatment against it.

'

Anticancer drug CBL0137 is highly effective against the most common type of infant leukaemia

28/07/2019


Findings just published by our researchers reveal that anticancer drug CBL0137, previously shown to be active against many different cancers, is also highly effective against MLL-rearranged leukaemia, including the most common type of infant leukaemia.

'

Therapy developed for Alzheimer’s Disease could offer hope to leukaemia patients

30/05/2019


In research published this week, scientists have found that a therapy originally developed to treat Alzheimer’s Disease could hold promise for children with T-cell acute lymphoblastic leukaemia.

'

Science Spotlight: leukaemia stem cells

27/05/2019


Leukaemia is a cancer of the blood cells and bone marrow. In the case of acute myeloid leukaemia, it starts with a single cell known as a ‘leukaemia stem cell’. This cell is also thought to be responsible for relapse after treatment. So what do we know about it?

'

Meet new Team Leader, Dr Charles de Bock

28/02/2019


Last year we recruited our first two Team Leaders in a newly created role. One of them was Dr Charles de Bock. He was working in Belgium at the time but has since returned to Australia, and he took up the Team Leader position last month. Let’s find out something about him.

'

Our researchers combine an old drug with a new one to starve neuroblastoma

18/02/2019


Our researchers have found a way to dramatically slow neuroblastoma growth, using a combination of drugs that starves cells of essential nutrients called polyamines.

'

Researcher travels 14,500 km to find better treatments for neuroblastoma

31/01/2019


Research Assistant Olivia Ciampa recently spent six months working in a collaborator’s lab at the Mayo Clinic, Minnesota, USA. I asked her why she went there, what it was like, and what she achieved.

'

Fundamental mechanism behind chemotherapy resistance revealed

17/12/2018


Groundbreaking research from our Leukaemia Biology Program has revealed how acute lymphoblastic leukaemia can become resistant to a class of anti-cancer drugs called glucocorticoids.

'

New imaging method could help treat and monitor neuroblastoma

19/11/2018


Our researchers have developed a method to measure the amount of copper inside neuroblastoma tumours. Published in the journal Theranostics, it offers a potential tool for treating and monitoring neuroblastoma.

'